Approvals/TGA/CAELYX doxorubicin hydrochloride 50 mg/25 mL concentrated injection vial

Approved

STANDARD

CAELYX doxorubicin hydrochloride 50 mg/25 mL concentrated injection vial

Baxter Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 14e7ff8b65459b58
Product Name: CAELYX doxorubicin hydrochloride 50 mg/25 mL concentrated injection vial
Artg Id: 79921
Artg Name: CAELYX doxorubicin hydrochloride 50 mg/25 mL concentrated injection vial
Sponsor: Baxter Healthcare Pty Ltd
Company Detail Path: /organization/baxter-healthcare-pty-ltd
Artg Date: 2001-12-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/877eedc631056f4d391b647fe0cd698c.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a202e961bfd01582e55dfdddb1cc9f5f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

14e7ff8b65459b58

Type

Standard